Peptide record

TPDB92964

dNP2-cys Blood-Brain Barrier Cell-penetrating Peptides modified_plain modified
22 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92964
dNP2-cys
Blood-Brain Barrier Cell-penetrating Peptides
Delivery and barrier-penetrating peptides
BBPpredict CPPsite3.0
modified_plain
Yes
A 22-aa modified multi-activity (Blood-Brain Barrier and Cell-penetrating Peptides) peptide sequence curated from BBPpredict and CPPsite3.0, with an available 3D structural model.
C-terminal: Addition of Cysteine Chemical: CFPE-labelled liposomes (cFd-Lip)
Sequence
KIKKVKKKGRKKIKKVKKKGRK
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
22 reviewed residue count
Addition of Cysteine Activity
CFPE-labelled liposomes (cFd-Lip) Activity
L Activity
Cationic Activity
Linear Activity
Free Activity
N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

bEnd.3 Cells , C6 Cell Line

Assay & Model

C6 glioma bearing BALB/c mice (female, 6-8 weeks old, 20 ± 2 g)
C6 glioma bearing BALB/c mice (female, 6-8 weeks old, 20 ± 2 g)

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L Cationic
Paclitaxel (PTX)
The acid-cleavable Fd-Lip significantly upregulated the uptake (p<0.05 vs cFd-Lip at pH 7.4, p<0.01 vs Fd-Lip). The FA-Lip showed significantly higher uptake than PEG-Lip. Moreover, dual modification of FA and dNP2 further enhanced the cellular uptake, showing synergistic effects.
In vitro and in vivo
CCCCCC
Evidence 2 Activity

Activity

Cell-penetrating Peptides

Target

Fr-Positive 4T1 Cells And Fr-Negative Nih-3T3 Cells And In Vitro 3D Spheroids Of 4T1 Cells Or 4T1 And Nih 3T3 Cells

Assay & Model

BALB/c mice (female, 6-8 weeks old, 20 ± 2 g)
BALB/c mice (female, 6-8 weeks old, 20 ± 2 g)

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Paclitaxel (PTX)
The endocytosis of cFd-Lip (pH 6.8) was higher than that of dNP2-Lip on folate receptor-positive 4T1 cells. The uptake of cFd-Lip by bEnd.3 monolayer cells was 1.01-, 1.26-, 19.90-, and 23.48-fold higher than that of Fd-Lip, dNP2-Lip, FA-Lip and PEG-Lip, respectively.
Endocytosis
In vitro and in vivo
CCGGGGGGGGGGHHHHTTSCCC
Additional Detail Fields 1 fields
CCCCCC CCGGGGGGGGGGHHHHTTSCCC